Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Integra Lifesciences (IART)

Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,495,781
  • Shares Outstanding, K 77,582
  • Annual Sales, $ 1,542 M
  • Annual Income, $ 67,740 K
  • EBIT $ 84 M
  • EBITDA $ 213 M
  • 60-Month Beta 1.08
  • Price/Sales 0.94
  • Price/Cash Flow 3.89
  • Price/Book 0.95

Options Overview Details

View History
  • Implied Volatility 88.00% ( +16.38%)
  • Historical Volatility 35.04%
  • IV Percentile 98%
  • IV Rank 64.07%
  • IV High 128.66% on 06/13/24
  • IV Low 15.48% on 05/21/24
  • Put/Call Vol Ratio 1.00
  • Today's Volume 144
  • Volume Avg (30-Day) 32
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 1,059
  • Open Int (30-Day) 1,056

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 0.39
  • Number of Estimates 8
  • High Estimate 0.42
  • Low Estimate 0.37
  • Prior Year 0.76
  • Growth Rate Est. (year over year) -48.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.81 +14.73%
on 10/03/24
20.02 -3.70%
on 10/16/24
+1.78 (+10.17%)
since 10/01/24
3-Month
16.81 +14.73%
on 10/03/24
24.40 -20.98%
on 08/02/24
-5.33 (-21.66%)
since 08/01/24
52-Week
16.81 +14.73%
on 10/03/24
45.42 -57.55%
on 02/20/24
-17.57 (-47.68%)
since 11/01/23

Most Recent Stories

More News
Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024

IART : 19.28 (+2.77%)
Here's Why You Should Hold IART Stock in Your Portfolio Now

Integra LifeSciences Holdings Corporation IART is well-poised to grow in the coming quarter, driven by healthy sales growth within its Tissue Technologies business despite product recall and manufacturing...

AXGN : 13.95 (-0.36%)
IART : 19.28 (+2.77%)
PAHC : 23.18 (+0.26%)
TMDX : 82.40 (+0.52%)
ON Semiconductor, Inspire Medical rise; Integra, Enstar Group fall, Monday, 7/29/2024

Stocks that traded heavily or had substantial price changes on Monday: ON Semiconductor, Inspire Medical rise; Integra, Enstar Group fall

CCK : 93.76 (+0.22%)
GH : 23.00 (+5.12%)
RVTY : 121.04 (+2.07%)
ESGR : 321.74 (-0.24%)
IART : 19.28 (+2.77%)
INSP : 190.71 (-2.22%)
ON : 70.99 (+0.71%)
Why Integra Lifesciences Stock Is Sinking Today

Q2 revenue and earnings beats didn't make up for the company's full-year guidance cut.

IART : 19.28 (+2.77%)
Integra: Q2 Earnings Snapshot

Integra: Q2 Earnings Snapshot

IART : 19.28 (+2.77%)
BioCryst Pharmaceuticals, Freshpet rise; Luminar, Integra fall, Monday, 5/6/2024

Stocks that traded heavily or had substantial price changes on Monday: BioCryst Pharmaceuticals, Freshpet rise; Luminar, Integra fall

THS : 36.82 (+1.21%)
IART : 19.28 (+2.77%)
FRPT : 133.69 (+0.87%)
BCRX : 8.43 (+5.24%)
NSSC : 38.59 (+0.29%)
Integra: Q1 Earnings Snapshot

Integra: Q1 Earnings Snapshot

IART : 19.28 (+2.77%)
Integra: Q4 Earnings Snapshot

Integra: Q4 Earnings Snapshot

IART : 19.28 (+2.77%)
Integra: Q3 Earnings Snapshot

Integra: Q3 Earnings Snapshot

IART : 19.28 (+2.77%)
IART Investors Have Opportunity to Lead Integra LifeSciences Holdings Corporation Securities Fraud Lawsuit

/PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action...

IART : 19.28 (+2.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty...

See More

Key Turning Points

3rd Resistance Point 20.40
2nd Resistance Point 20.05
1st Resistance Point 19.67
Last Price 19.28
1st Support Level 18.94
2nd Support Level 18.59
3rd Support Level 18.21

See More

52-Week High 45.42
Fibonacci 61.8% 34.49
Fibonacci 50% 31.11
Fibonacci 38.2% 27.74
Last Price 19.28
52-Week Low 16.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar